Replies to post #504126 on NorthWest Biotherapeutics Inc (NWBO)

[Bob_LobLaw]

Agreed. Something went wrong with the Journal and we are a long ways off from any meaningful catalyst hence the 250mm shares up for grabs at 60 cents. My money is on egos clashing and having to start over looking for another journal after the 1st backed out.

[flipper44]

You know judge, even though the data is unblinded to insiders at this point, in a way we now have two data sets. The second data set is akin to long term follow up on the trial. Being that they can observe the data, it could be they (everyone working on the journal) are waiting on some obvious statistical time passage regarding some other secondary endpoints. Who knows, but I highly doubt this is a battle between editors and reviewers at this point. I’m flummoxed, but that’s my latest guess.

[MasterBlastr]

I start to think that the whole JA exercise is just a creative way to kick the can down the road, and off a cliff if they can't stop it now.